Abstract
The U.S. FDA recently ushered in a new era with the launch of its very own generative artificial intelligence (AI) tool. Designed to assist employees across various functions, from scientific reviewers to investigators, Elsa is being heralded by the FDA as a significant step toward modernizing agency operations and enhancing efficiency.
Key Data
-
Publication Date12 June 2025
-
Primary AuthorErika Roberts
-
SourceMed device Online
-
LanguageEnglish
Click below to visit original source: